For years, companies across industries have struggled to identify who exactly is responsible for quality assurance and regulatory affairs – and manufacturers within the pharmaceutical space are no different. While some organizations note that everyone on the team is responsible, others name a specific department or upper management group. Without clear ownership, quality assurance and regulatory affairs often falls to the wayside amidst teams’ busy day-to-day operations, creating the potential for crucial considerations to fall through the cracks.